A more recent study showed increased expression of GSDMD in both oligodendrocytes and microglia in the brain tissues of patients with progressive multiple sclerosis (P-MS), and GSDMD knockout in a cuprizone (CPZ)-induced demyelination mouse model reduced demyelination and neuronal axon damage [155]. The gene discussed is GSDMD; the disease is myeloid sarcoma.